Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs267607048
rs267607048
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
CUI: C3501846
Disease:
Noonan-Like Syndrome With Loose Anagen Hair
0.050 GeneticVariation BEFREE Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM 607721) is caused by a heterozygous c.4A>G mutation in SHOC2. 26096762 2015
dbSNP: rs267607048
rs267607048
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
CUI: C3501846
Disease:
Noonan-Like Syndrome With Loose Anagen Hair
0.050 GeneticVariation BEFREE Here, we report on the occurrence of severe hydrops in a newborn heterozygous for the invariant c.4A>G missense change in SHOC2 which underlies Noonan-like syndrome with loose anagen hair, documenting that it represents a clinically relevant complication in this condition, shared by RASopathies. 24458587 2014
dbSNP: rs267607048
rs267607048
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
CUI: C3501846
Disease:
Noonan-Like Syndrome With Loose Anagen Hair
0.050 GeneticVariation BEFREE Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM 607721) due to a missense mutation c.4A>G in SHOC2 predicting p.Ser2Gly has been described recently. 24458596 2014
dbSNP: rs267607048
rs267607048
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
CUI: C3501846
Disease:
Noonan-Like Syndrome With Loose Anagen Hair
0.050 GeneticVariation BEFREE Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM 607721), recently related to the invariant c.4A>G missense change in SHOC2, is characterized by features reminiscent of Noonan syndrome. 22419608 2012
dbSNP: rs267607048
rs267607048
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
CUI: C3501846
Disease:
Noonan-Like Syndrome With Loose Anagen Hair
0.050 GeneticVariation BEFREE Twenty-five subjects with a relatively consistent phenotype previously termed Noonan-like syndrome with loose anagen hair (MIM607721) shared the 4A>G missense change in SHOC2 (producing an S2G amino acid substitution) that introduces an N-myristoylation site, resulting in aberrant targeting of SHOC2 to the plasma membrane and impaired translocation to the nucleus upon growth factor stimulation. 19684605 2009